应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
CADL Candel Therapeutics, Inc.
休市中 12-12 16:00:00 EST
6.35
-0.12
-1.85%
盘后
6.49
+0.14
+2.27%
19:50 EST
最高
6.55
最低
6.16
成交量
141.48万
今开
6.47
昨收
6.47
日振幅
6.03%
总市值
3.49亿
流通市值
2.89亿
总股本
5,490万
成交额
906.96万
换手率
3.11%
流通股本
4,548万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Candel Therapeutics, Inc.盘中异动 股价大跌5.03%报4.53美元
市场透视 · 12-01
Candel Therapeutics, Inc.盘中异动 股价大跌5.03%报4.53美元
Candel Therapeutics 第三季度净收入为-1126.9万美元
投资观察 · 11-20
Candel Therapeutics 第三季度净收入为-1126.9万美元
Candel Therapeutics, Inc.:预计2026年第一季度发布第二阶段非小细胞肺癌长期存活者数据,第二阶段将在2026年第二季度启动
美股速递 · 11-13
Candel Therapeutics, Inc.:预计2026年第一季度发布第二阶段非小细胞肺癌长期存活者数据,第二阶段将在2026年第二季度启动
Candel Therapeutics 第三季度营业收入亏损1320.7万美元,与Ibes预期的1180万美元相比更显逊色
美股速递 · 11-13
Candel Therapeutics 第三季度营业收入亏损1320.7万美元,与Ibes预期的1180万美元相比更显逊色
Candel Therapeutics任命系统免疫学专家Bali Pulendran博士为研究顾问委员会成员
美股速递 · 10-16
Candel Therapeutics任命系统免疫学专家Bali Pulendran博士为研究顾问委员会成员
Candel Therapeutics在Astro 2025会议上展示Can-2409治疗局部前列腺癌的3期临床试验
美股速递 · 09-29
Candel Therapeutics在Astro 2025会议上展示Can-2409治疗局部前列腺癌的3期临床试验
Candel Therapeutics, Inc.盘中异动 临近收盘大幅上涨5.03%报5.54美元
市场透视 · 09-27
Candel Therapeutics, Inc.盘中异动 临近收盘大幅上涨5.03%报5.54美元
Candel Therapeutics任命知名免疫疗法先驱Carl H. June博士加入研究咨询委员会
美股速递 · 09-02
Candel Therapeutics任命知名免疫疗法先驱Carl H. June博士加入研究咨询委员会
Candel Therapeutics, Inc.盘中异动 快速跳水5.06%报7.51美元
市场透视 · 03-04
Candel Therapeutics, Inc.盘中异动 快速跳水5.06%报7.51美元
Candel Therapeutics, Inc.盘中异动 早盘股价大涨5.14%报8.90美元
市场透视 · 02-28
Candel Therapeutics, Inc.盘中异动 早盘股价大涨5.14%报8.90美元
加拿大投资银行集团:维持Candel Therapeutics(CADL.US)评级,由买入调整至买入评级, 目标价由20.00美元调整至25.00美元。
金融界 · 02-27
加拿大投资银行集团:维持Candel Therapeutics(CADL.US)评级,由买入调整至买入评级, 目标价由20.00美元调整至25.00美元。
Candel Therapeutics, Inc.盘中异动 股价大跌5.28%报11.57美元
市场透视 · 02-21
Candel Therapeutics, Inc.盘中异动 股价大跌5.28%报11.57美元
Candel Therapeutics(CADL.US)获花旗首次覆盖,给予买入评级, 目标价25.00美元。
金融界 · 02-20
Candel Therapeutics(CADL.US)获花旗首次覆盖,给予买入评级, 目标价25.00美元。
Candel Therapeutics, Inc.盘中异动 早盘快速拉升5.36%报10.03美元
市场透视 · 02-19
Candel Therapeutics, Inc.盘中异动 早盘快速拉升5.36%报10.03美元
Candel Therapeutics(CADL.US)获加拿大投资银行集团首次覆盖,给予买入评级, 目标价20.00美元。
金融界 · 02-19
Candel Therapeutics(CADL.US)获加拿大投资银行集团首次覆盖,给予买入评级, 目标价20.00美元。
Candel Therapeutics, Inc.盘中异动 早盘大幅拉升5.08%报9.51美元
市场透视 · 02-18
Candel Therapeutics, Inc.盘中异动 早盘大幅拉升5.08%报9.51美元
Candel Therapeutics, Inc.盘中异动 早盘股价大涨8.08%
市场透视 · 02-07
Candel Therapeutics, Inc.盘中异动 早盘股价大涨8.08%
Candel Therapeutics, Inc.盘中异动 急速拉升5.45%报7.54美元
市场透视 · 02-04
Candel Therapeutics, Inc.盘中异动 急速拉升5.45%报7.54美元
Candel Therapeutics, Inc.盘中异动 下午盘股价大跌5.01%
市场透视 · 01-28
Candel Therapeutics, Inc.盘中异动 下午盘股价大跌5.01%
Candel Therapeutics, Inc.盘中异动 急速跳水5.01%报7.31美元
市场透视 · 01-17
Candel Therapeutics, Inc.盘中异动 急速跳水5.01%报7.31美元
公司概况
公司名称:
Candel Therapeutics, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Candel Therapeutics, Inc.于2003年6月在特拉华州注册成立。该公司是一家临床阶段的生物制药公司,专注于开发可引发个体化、全身性抗肿瘤免疫反应的现成病毒免疫疗法,以帮助患者对抗癌症。
发行价格:
--
{"stockData":{"symbol":"CADL","market":"US","secType":"STK","nameCN":"Candel Therapeutics, Inc.","latestPrice":6.35,"timestamp":1765573200000,"preClose":6.47,"halted":0,"volume":1414832,"hourTrading":{"tag":"盘后","latestPrice":6.4939,"preClose":6.35,"latestTime":"19:50 EST","volume":5655,"amount":35999.0097,"timestamp":1765587045192},"delay":0,"floatShares":45478500,"shares":54898303,"eps":-0.472894,"marketStatus":"休市中","change":-0.12,"latestTime":"12-12 16:00:00 EST","open":6.474,"high":6.55,"low":6.16,"amount":9069580.195788799,"amplitude":0.060278,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.472894,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"adr":0,"listingDate":1627358400000,"exchange":"NASDAQ","adjPreClose":6.47,"preHourTrading":{"tag":"盘前","latestPrice":6.55,"preClose":6.47,"latestTime":"09:28 EST","volume":10311,"amount":67379.9794437,"timestamp":1765549680080},"postHourTrading":{"tag":"盘后","latestPrice":6.4939,"preClose":6.35,"latestTime":"19:50 EST","volume":5655,"amount":35999.0097,"timestamp":1765587045192},"volumeRatio":0.9728180915787661,"impliedVol":1.2435,"impliedVolPercentile":0.628},"requestUrl":"/m/hq/s/CADL/wiki","defaultTab":"wiki","newsList":[{"id":"2588777042","title":"Candel Therapeutics, Inc.盘中异动 股价大跌5.03%报4.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588777042","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588777042?lang=zh_cn&edition=full","pubTime":"2025-12-01 23:21","pubTimestamp":1764602497,"startTime":"0","endTime":"0","summary":"北京时间2025年12月01日23时21分,Candel Therapeutics, Inc.股票出现波动,股价快速下跌5.03%。Candel Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.36%。其相关个股中,Q32 Bio Inc.、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Kala Bio, Inc.涨幅较大,Q32 Bio Inc.、Kala Bio, Inc.、Aditxt, Inc.较为活跃,换手率分别为967.94%、812.69%、70.33%,振幅较大的相关个股有Pasithea Therapeutics Corp C/Wts 12/08/2026 、Q32 Bio Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029,振幅分别为101.36%、100.45%、64.00%。Candel Therapeutics, Inc.公司简介:Candel Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发和商业化病毒免疫疗法以帮助患者抗癌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512012321379524ebbd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512012321379524ebbd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","CADL","LENZ","BK4539"],"gpt_icon":0},{"id":"1101026601","title":"Candel Therapeutics 第三季度净收入为-1126.9万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1101026601","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101026601?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:39","pubTimestamp":1763573991,"startTime":"0","endTime":"0","summary":"11月13日 - Candel Therapeutics 第三季度运营收入为-1320.7万美元,而IBES预估为-1180万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CADL","BK4139","BK4539"],"gpt_icon":0},{"id":"1178070062","title":"Candel Therapeutics, Inc.:预计2026年第一季度发布第二阶段非小细胞肺癌长期存活者数据,第二阶段将在2026年第二季度启动","url":"https://stock-news.laohu8.com/highlight/detail?id=1178070062","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178070062?lang=zh_cn&edition=full","pubTime":"2025-11-13 21:27","pubTimestamp":1763040434,"startTime":"0","endTime":"0","summary":"Candel Therapeutics, Inc.:预计2026年第一季度发布第二阶段非小细胞肺癌长期存活者数据,第二阶段将在2026年第二季度启动","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CADL","BK4139","BK4539"],"gpt_icon":0},{"id":"1157392910","title":"Candel Therapeutics 第三季度营业收入亏损1320.7万美元,与Ibes预期的1180万美元相比更显逊色","url":"https://stock-news.laohu8.com/highlight/detail?id=1157392910","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157392910?lang=zh_cn&edition=full","pubTime":"2025-11-13 21:25","pubTimestamp":1763040312,"startTime":"0","endTime":"0","summary":"Candel Therapeutics 第三季度营业收入亏损1320.7万美元,明显低于Ibes预期的1180万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CADL","BK4539"],"gpt_icon":0},{"id":"1152175334","title":"Candel Therapeutics任命系统免疫学专家Bali Pulendran博士为研究顾问委员会成员","url":"https://stock-news.laohu8.com/highlight/detail?id=1152175334","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152175334?lang=zh_cn&edition=full","pubTime":"2025-10-16 20:07","pubTimestamp":1760616430,"startTime":"0","endTime":"0","summary":"Candel Therapeutics任命系统免疫学领域的顶尖专家Bali Pulendran博士为其研究顾问委员会成员。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","CADL"],"gpt_icon":0},{"id":"1189914840","title":"Candel Therapeutics在Astro 2025会议上展示Can-2409治疗局部前列腺癌的3期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1189914840","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189914840?lang=zh_cn&edition=full","pubTime":"2025-09-29 20:06","pubTimestamp":1759147586,"startTime":"0","endTime":"0","summary":"Candel Therapeutics在Astro 2025会议上公布了其Can-2409药物针对局部前列腺癌的3期临床试验研究进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","CADL"],"gpt_icon":0},{"id":"2570558388","title":"Candel Therapeutics, Inc.盘中异动 临近收盘大幅上涨5.03%报5.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2570558388","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570558388?lang=zh_cn&edition=full","pubTime":"2025-09-27 03:49","pubTimestamp":1758916179,"startTime":"0","endTime":"0","summary":"北京时间2025年09月27日03时49分,Candel Therapeutics, Inc.股票出现波动,股价大幅上涨5.03%。截至发稿,该股报5.54美元/股,成交量60.4053万股,换手率1.10%,振幅5.50%。Candel Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.20%。Candel Therapeutics, Inc.公司简介:Candel Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发和商业化病毒免疫疗法以帮助患者抗癌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250927034939a6a0bd6d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250927034939a6a0bd6d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","CADL","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"1146905354","title":"Candel Therapeutics任命知名免疫疗法先驱Carl H. June博士加入研究咨询委员会","url":"https://stock-news.laohu8.com/highlight/detail?id=1146905354","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146905354?lang=zh_cn&edition=full","pubTime":"2025-09-02 20:05","pubTimestamp":1756814732,"startTime":"0","endTime":"0","summary":"Candel Therapeutics任命知名免疫疗法先驱Carl H. June博士加入研究咨询委员会","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CADL","BK4139","BK4539"],"gpt_icon":0},{"id":"2516460823","title":"Candel Therapeutics, Inc.盘中异动 快速跳水5.06%报7.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516460823","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516460823?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:57","pubTimestamp":1741100277,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时57分,Candel Therapeutics, Inc.股票出现波动,股价快速跳水5.06%。Candel Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.40%。Candel Therapeutics, Inc.公司简介:Candel Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发和商业化病毒免疫疗法以帮助患者抗癌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030422575896394ca5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030422575896394ca5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","LENZ","CADL"],"gpt_icon":0},{"id":"2514382443","title":"Candel Therapeutics, Inc.盘中异动 早盘股价大涨5.14%报8.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514382443","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514382443?lang=zh_cn&edition=full","pubTime":"2025-02-28 00:17","pubTimestamp":1740673066,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日00时17分,Candel Therapeutics, Inc.股票出现波动,股价快速上涨5.14%。截至发稿,该股报8.90美元/股,成交量38.8565万股,换手率0.87%,振幅7.20%。Candel Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.64%。Candel Therapeutics, Inc.公司简介:Candel Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发和商业化病毒免疫疗法以帮助患者抗癌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280017469895260f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280017469895260f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CADL","LENZ","BK4139","BK4539"],"gpt_icon":0},{"id":"2514586310","title":"加拿大投资银行集团:维持Candel Therapeutics(CADL.US)评级,由买入调整至买入评级, 目标价由20.00美元调整至25.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514586310","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514586310?lang=zh_cn&edition=full","pubTime":"2025-02-27 01:14","pubTimestamp":1740590052,"startTime":"0","endTime":"0","summary":"加拿大投资银行集团:维持Candel Therapeutics(CADL.US)评级,由买入调整至买入评级, 目标价由20.00美元调整至25.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/27011448413920.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","CADL"],"gpt_icon":0},{"id":"2513398296","title":"Candel Therapeutics, Inc.盘中异动 股价大跌5.28%报11.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513398296","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513398296?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:31","pubTimestamp":1740148276,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时31分,Candel Therapeutics, Inc.股票出现波动,股价大幅下跌5.28%。Candel Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.33%。其相关个股中,Osr Holdings, Inc.、Nkgen Biotech, Inc.、Acelyrin, Inc.涨幅较大,Nkgen Biotech, Inc.、Aditxt, Inc.、蓝鸟生物较为活跃,换手率分别为69.10%、60.32%、17.96%,振幅较大的相关个股有Osr Holdings, Inc.、Gain Therapeutics, Inc.、Windtree Therapeutics, Inc.,振幅分别为14.17%、10.21%、7.71%。Candel Therapeutics, Inc.公司简介:Candel Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发和商业化病毒免疫疗法以帮助患者抗癌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223116abd7af50&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223116abd7af50&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CADL","LENZ","BK4139","BK4539"],"gpt_icon":0},{"id":"2512448497","title":"Candel Therapeutics(CADL.US)获花旗首次覆盖,给予买入评级, 目标价25.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2512448497","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512448497?lang=zh_cn&edition=full","pubTime":"2025-02-20 19:10","pubTimestamp":1740049838,"startTime":"0","endTime":"0","summary":"Candel Therapeutics(CADL.US)获花旗首次覆盖,给予买入评级, 目标价25.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/20191048285026.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","CADL"],"gpt_icon":0},{"id":"2512488088","title":"Candel Therapeutics, Inc.盘中异动 早盘快速拉升5.36%报10.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512488088","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512488088?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:42","pubTimestamp":1739976126,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时42分,Candel Therapeutics, Inc.股票出现异动,股价急速上涨5.36%。Candel Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.21%。其相关个股中,Osr Holdings Inc C/Wts 02/09/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Aditxt, Inc.涨幅较大,Aditxt, Inc.、Alzamend Neuro, Inc.、Chemomab Therapeutics Ltd较为活跃,换手率分别为297.03%、214.17%、67.66%,振幅较大的相关个股有Osr Holdings Inc C/Wts 02/09/2028 、Allogene Therapeutics, Inc.、Omega Therapeutics, Inc.,振幅分别为207.68%、36.97%、20.84%。Candel Therapeutics, Inc.公司简介:Candel Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发和商业化病毒免疫疗法以帮助患者抗癌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219224206988b3374&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219224206988b3374&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","LENZ","CADL"],"gpt_icon":0},{"id":"2512177950","title":"Candel Therapeutics(CADL.US)获加拿大投资银行集团首次覆盖,给予买入评级, 目标价20.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2512177950","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512177950?lang=zh_cn&edition=full","pubTime":"2025-02-19 18:42","pubTimestamp":1739961736,"startTime":"0","endTime":"0","summary":"Candel Therapeutics(CADL.US)获加拿大投资银行集团首次覆盖,给予买入评级, 目标价20.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/19184248263432.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","CADL"],"gpt_icon":0},{"id":"2512323165","title":"Candel Therapeutics, Inc.盘中异动 早盘大幅拉升5.08%报9.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512323165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512323165?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:30","pubTimestamp":1739889054,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时30分,Candel Therapeutics, Inc.股票出现异动,股价急速上涨5.08%。截至发稿,该股报9.51美元/股,成交量7.9079万股,换手率0.18%,振幅0.00%。Candel Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.00%。Candel Therapeutics, Inc.公司简介:Candel Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发和商业化病毒免疫疗法以帮助患者抗癌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223054abd3aebc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223054abd3aebc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4539","CADL"],"gpt_icon":0},{"id":"2509574462","title":"Candel Therapeutics, Inc.盘中异动 早盘股价大涨8.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509574462","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509574462?lang=zh_cn&edition=full","pubTime":"2025-02-07 22:31","pubTimestamp":1738938713,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日22时31分,Candel Therapeutics, Inc.股票出现波动,股价急速上涨8.08%。Candel Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.02%。其相关个股中,Conduit Pharmaceuticals Inc.、Engene Holdings Inc C/Wts 31/10/2028 Cl A、Nutriband Inc.涨幅较大,Conduit Pharmaceuticals Inc.、Lipella Pharmaceuticals Inc.、Aditxt, Inc.较为活跃,换手率分别为1050.29%、39.51%、33.36%,振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Nutriband Inc.、Renovorx, Inc.,振幅分别为30.97%、13.78%、10.27%。Candel Therapeutics, Inc.公司简介:Candel Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发和商业化病毒免疫疗法以帮助患者抗癌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207223153a23d2348&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207223153a23d2348&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CADL","BK4139","BK4539","LENZ"],"gpt_icon":0},{"id":"2509657754","title":"Candel Therapeutics, Inc.盘中异动 急速拉升5.45%报7.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509657754","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509657754?lang=zh_cn&edition=full","pubTime":"2025-02-04 23:49","pubTimestamp":1738684174,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日23时49分,Candel Therapeutics, Inc.股票出现异动,股价快速拉升5.45%。Candel Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.77%。其相关个股中,Azitra Inc、Evaxion Biotech As、Quoin Pharmaceuticals Ltd涨幅较大,Azitra Inc、Evaxion Biotech As、Enveric Biosciences, Inc.较为活跃,换手率分别为1567.44%、906.35%、228.59%,振幅较大的相关个股有Azitra Inc、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Viracta Therapeutics, Inc.,振幅分别为66.50%、49.88%、44.22%。Candel Therapeutics, Inc.公司简介:Candel Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发和商业化病毒免疫疗法以帮助患者抗癌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204234934a239383f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204234934a239383f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CADL","BK4539"],"gpt_icon":0},{"id":"2506468585","title":"Candel Therapeutics, Inc.盘中异动 下午盘股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506468585","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506468585?lang=zh_cn&edition=full","pubTime":"2025-01-28 02:22","pubTimestamp":1738002153,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日02时22分,Candel Therapeutics, Inc.股票出现异动,股价急速下跌5.01%。Candel Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.77%。其相关个股中,Akero Therapeutics, Inc.、Dogwood Therapeutics, Inc.、89Bio, Inc.涨幅较大,Onconetix, Inc.、Dogwood Therapeutics, Inc.、Allarity Therapeutics, Inc.较为活跃,换手率分别为2148.78%、994.74%、256.30%,振幅较大的相关个股有Dogwood Therapeutics, Inc.、Onconetix, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028,振幅分别为108.60%、99.77%、65.16%。Candel Therapeutics, Inc.公司简介:Candel Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发和商业化病毒免疫疗法以帮助患者抗癌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501280222349874d26d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501280222349874d26d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","CADL","LENZ","BK4139"],"gpt_icon":0},{"id":"2504467164","title":"Candel Therapeutics, Inc.盘中异动 急速跳水5.01%报7.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504467164","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504467164?lang=zh_cn&edition=full","pubTime":"2025-01-17 22:37","pubTimestamp":1737124623,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日22时37分,Candel Therapeutics, Inc.股票出现波动,股价急速跳水5.01%。Candel Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.49%。其相关个股中,Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Revolution Medicines Inc C/Wts 17/12/2026 、Surrozen Inc C/Wts 01/08/2031 涨幅较大,Aditxt, Inc.、Aeon Biopharma, Inc.、Silexion Therapeutics Corp较为活跃,换手率分别为101.41%、15.66%、8.61%,振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Psyence Biomedical Ltd C/Wts 25/01/2029、Surrozen Inc C/Wts 01/08/2031 ,振幅分别为44.21%、31.14%、25.64%。Candel Therapeutics, Inc.公司简介:Candel Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发和商业化病毒免疫疗法以帮助患者抗癌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117223703986a1650&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117223703986a1650&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CADL","LENZ","BK4539","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.candeltx.com","stockEarnings":[{"period":"1week","weight":0.1914},{"period":"1month","weight":0.2907},{"period":"3month","weight":0.3257},{"period":"6month","weight":0.2378},{"period":"1year","weight":-0.352},{"period":"ytd","weight":-0.2684}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Candel Therapeutics, Inc.于2003年6月在特拉华州注册成立。该公司是一家临床阶段的生物制药公司,专注于开发可引发个体化、全身性抗肿瘤免疫反应的现成病毒免疫疗法,以帮助患者对抗癌症。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.079266},{"month":2,"riseRate":0.5,"avgChangeRate":0.090279},{"month":3,"riseRate":0.25,"avgChangeRate":-0.133894},{"month":4,"riseRate":0.25,"avgChangeRate":0.747487},{"month":5,"riseRate":1,"avgChangeRate":0.149002},{"month":6,"riseRate":0,"avgChangeRate":-0.170269},{"month":7,"riseRate":0.25,"avgChangeRate":0.011025},{"month":8,"riseRate":0.8,"avgChangeRate":0.068985},{"month":9,"riseRate":0.4,"avgChangeRate":-0.01705},{"month":10,"riseRate":0.4,"avgChangeRate":-0.110246},{"month":11,"riseRate":0,"avgChangeRate":-0.079739},{"month":12,"riseRate":0.8,"avgChangeRate":0.317783}],"exchange":"NASDAQ","name":"Candel Therapeutics, Inc.","nameEN":"Candel Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Candel Therapeutics, Inc.(CADL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Candel Therapeutics, Inc.(CADL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Candel Therapeutics, Inc.,CADL,Candel Therapeutics, Inc.股票,Candel Therapeutics, Inc.股票老虎,Candel Therapeutics, Inc.股票老虎国际,Candel Therapeutics, Inc.行情,Candel Therapeutics, Inc.股票行情,Candel Therapeutics, Inc.股价,Candel Therapeutics, Inc.股市,Candel Therapeutics, Inc.股票价格,Candel Therapeutics, Inc.股票交易,Candel Therapeutics, Inc.股票购买,Candel Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Candel Therapeutics, Inc.(CADL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Candel Therapeutics, Inc.(CADL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}